About Lancet Capital
Lancet Capital, the first SBIC affiliated with an academic medical center, was founded in 1998 by William Golden and George Sing to create value for investors and founders/management of early stage biomedical portfolio companies. Lancet invests in exceptional researchers, clinicians and entrepreneurs to commercialize innovative technologies in the biomedical field.
Investment Details
Investment Range
Not specified
Investment Stage
Various stages
Industry Focus
Education, Healthcare, VR/AR
Investor Type
Venture Capital
Investment Focus
Focus Areas
Investment Stages